These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27311619)

  • 1. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
    de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced liver injury with autoimmune features.
    deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
    Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
    Chalasani N; Li YJ; Dellinger A; Navarro V; Bonkovsky H; Fontana RJ; Gu J; Barnhart H; Phillips E; Lammert C; Schwantes-An TH; Nicoletti P; Kleiner DE; Hoofnagle JH;
    J Hepatol; 2023 Feb; 78(2):293-300. PubMed ID: 36152763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles.
    Stephens C; Castiella A; Gomez-Moreno EM; Otazua P; López-Nevot MÁ; Zapata E; Ortega-Alonso A; Ruiz-Cabello F; Medina-Cáliz I; Robles-Díaz M; Soriano G; Roman E; Hallal H; Moreno-Planas JM; Prieto M; Andrade RJ; Lucena MI
    Pharmacogenet Genomics; 2016 Sep; 26(9):414-22. PubMed ID: 27206238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
    Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
    J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
    García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
    Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
    Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
    J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
    Weber S; Gerbes AL
    Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 10. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
    Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
    Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
    Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
    Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
    Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
    Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in China.
    Wu J; Guo N; Zhu L; Zhang X; Xiong C; Liu J; Xu Y; Fan J; Yu J; Pan Q; Yang J; Liang H; Jin X; Ye S; Wang W; Liu C; Zhang J; Li G; Jiang B; Cao H; Li L
    Emerg Microbes Infect; 2020; 9(1):332-340. PubMed ID: 32037983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
    Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW
    J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
    Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
    Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
    Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
    Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
    Weber S; Benesic A; Rotter I; Gerbes AL
    Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
    Maeda Y; Migita K; Higuchi O; Mukaino A; Furukawa H; Komori A; Nakamura M; Hashimoto S; Nagaoka S; Abiru S; Yatsuhashi H; Matsuo H; Kawakami A; Yasunami M; Nakane S
    PLoS One; 2016; 11(1):e0146048. PubMed ID: 26807576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].
    Zhang HP; Yan HP; Lou JL; Huang CY; Ma YX; Li LJ; Han Y; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1182-1187. PubMed ID: 35045634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.